3Win Corp. Executes Definitive Agreement to Acquire Serenus Global, Inc.
3Win Corp., a Tempe, Arizona-based global wholesale distributor of CCELL® vape products announces today that it has entered into a definitive agreement to acquire Serenus...
Harmoniously.com to Participate in the Renowned HLTH Conference in Las Vegas
Evidence-Based Psychedelic Medicine Company Harmoniously.com to Join Leading Health Care Conference Harmoniously.com, a leading name in the field of psychedelic medicine and integrated wellness, is...
Core One Labs’, Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
Core One's Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark OfficeVANCOUVER, BC / ACCESSWIRE / August 1, 2023 /...
Core One’s Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease
VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the "Company" or "Core One"), is excited to share positive...
MindBio Therapeutics World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder Begins Pre-Screening Participants
Patients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials registry approvedWorld first take-home approvals...
Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing intravenous-infused...
Core One’s Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
VANCOUVER, BC / ACCESSWIRE / July 11, 2023 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company") is pleased to announce that its...
Home of Ayahuasca Expands Offerings With Extended 3-to-6-Month Retreats for Profound Transformation
Extended Plant Medicine Retreats are Designed for Deep Personal Evolution in the Jungle of Peru Home of Ayahuasca, a retreat center specializing in plant medicine...
MindBio Therapeutics Co-Founders Appear in Leading Australian Financial News Publication Ahead of Medicinal Psychedelics Legalisation in Australia
MindBio and Co-founders profiled in Australian Financial ReviewRegulatory changes in Australia arrive 1 July 2023CEO lands in Canada for investor and conference presentationsVANCOUVER, BC /...
MindBio Therapeutics CEO To Present at Emerging Equities Life Sciences VIP Event and Showcase MindBio’s Research at Upcoming MAPS Psychedelics Science Conference in Colorado
CEO to present at upcoming industry and investor eventsMindBio scientists to deliver clinical trials results poster presentation at MAPS Psychedelic Science conference in Denver, ColoradoCompany...